RegeneRx Biopharmaceuticals (RGRX) SEC Filings & 10K Form

$0.0014
0.00 (0.00%)
(As of 04/26/2024 ET)

Recent RegeneRx Biopharmaceuticals SEC Filings

DateFilerForm TypeView
08/07/2023
2:57 PM
RegeneRx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
4:13 PM
RegeneRx Biopharmaceuticals (Filer)
Form DEF 14A
07/10/2023
4:19 PM
RegeneRx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
3:35 PM
Essetifin SPA (Filed by)
RegeneRx Biopharmaceuticals (Subject)
Form SC 13D/A
07/06/2023
3:30 PM
APTAFIN S P A (Reporting)
Cavazza Enrico (Reporting)
Cavazza Francesca (Reporting)
CAVAZZA PAOLO (Reporting)
Cavazza Preta Martina (Reporting)
Cavazza Silvia (Reporting)
Essetifin SPA (Reporting)
RegeneRx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:RGRX) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners